October 25, 2018
A California federal judge said Thursday he'll likely allow Valeant to proceed with lawsuits alleging two pharmaceutical companies falsely advertised U.S. Food and Drug Administration approval of copycat versions of its irritable bowel syndrome drug, saying he didn't buy arguments that potential appeals to the FDA preempted the suits.